COVID-19 Research

Research

COVID-19 Studies

NameTypeFunderSponsorStatusApproval Date
SIREN - SARS-COV2 immunity and reinfection evaluationObservationalnot availablePublic Health EnglandIn Setup, HRA Approval Received18 May 2020
CROWN CORONATIONInterventionalBill & Melinda Gates Foundation; Washington University in St Louis (USA)University College LondonIn Setup, Pending HRA Approval13 May 2020
PROTECTInterventionalnot availableCambridge University Hospitals NHS Foundation Trust and University of CambridgeIn Setup, Pending HRA Approval13 May 2020
CATALYSTInterventionalnot availableUniversity of BirminghamOpen to Recruitment11 May 2020
COG-UK HOCIInterventionalNIHR/UKRIUniversity College Londonnot available11 May 2020
DEFINEInterventionalnot availablenot availablenot available11 May 2020
TACTICInterventionalnot available Cambridge University Hospitals NHS Foundation TrustOpen to recruitment11 May 2020
OSCARInterventionalGlaxoSmithKlineGlaxoSmithKlinenot available07 May 2020
MERMAIDS - ARIObservationalnot availableUniversity of Oxfordnot available07 May 2020
Investigating a Vaccine Against COVID-19 (COV002)InterventionalNIHR/UKRIUniversity of OxfordIn Setup, HRA Approval Received30 April 2020
ACCORDInterventionalNIHR/UKRIUNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUSTIn Setup, HRA Approval Received21 April 2020
A randomized double blind placebo controlled trial of Brensocatib in patients with severe COVID-19 (STOP-COVID19)InterventionalInsmed IncUniversity of Dundeenot available21 April 2020
Neonatal complications of coronavirus disease (COVID-19)ObservationalPolicy Research ProgrammeUniversity of Oxfordnot available21 April 2020
Pregnancy and Neonatal Outcomes in COVID-19ObservationalNIHR/UKRIImperial College of Science, Technology and MedicineIn Setup, HRA Approval Received18 April 2020
VIrus WatchObservationalMedical Research Councilnot availablenot available18 April 2020
DeVENTInterventionalEuropean CommissionImperial College of Science, Technology and MedicineOpen, With Recruitment13 April 2020
RECOVERY - Respiratory SupportInterventionalNIHR Central Commissioing Facility (CCF)University of WarwickOpen, With Recruitment13 April 2020
CANCOVIDInterventionalNovartisNovartisIn Setup, Pending HRA Approval06 April 2020
ILIAD 7InterventionalRevImmuneRevImmunenot available06 April 2020
RUXCOVIDInterventionalNovartisNovartisIn Setup, Pending HRA Approval06 April 2020
What's the STORY ObservationalNIHR/UKRIUniversity of Oxfordnot available06 April 2020
Repair of ARDS by Stromal Cell Administration (REALIST)InterventionalWellcome TrustBelfast Health & Social Care TrustOpen to Recruitment02 April 2020
Coronavirus infection in immunosuppressed childrenObservationalBritish Paediatric Allergy, Immunity and Infection GroupUNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUSTOpen, With Recruitment02 April 2020
DIAMONDS SEARCH v1ObservationalEuropean CommissionImperial College of Science, Technology and MedicineIn Setup, HRA Approval Received02 April 2020
GenOMICCObservationalWellcome TrustNHS LothianOpen, With Recruitment02 April 2020
Chloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)Interventionalnot availablenot availablenot available30 March 2020
SARS-CoV-2 infectionInterventionalSYNAIRGEN RESEARCH LIMITEDSYNAIRGEN RESEARCH LIMITEDOpen, With Recruitment30 March 2020
Adaptive COVID-19 Treatment Trial (ACTT)InterventionalNational Institutes of Health (NIH), United StatesUniversity of Minnesota (USA)Open, With Recruitment27 March 2020
REMAP-CAPInterventionalEuropean CommissionUniversity Medical Centre Utrecht (Netherlands)Open, With Recruitment27 March 2020
A study to evaluate TCZ in patients with severe COVID-19 PneumoniaInterventionalF. Hoffmann-La Roche LtdF. Hoffmann-La Roche LtdOpen to Recruitment26 March 2020
5773 Safety and Antiviral Activity of Remdesivir for severe COVID-19InterventionalGilead Sciences IncGilead Sciences IncOpen to Recruitment25 March 2020
5774 Safety & Antiviral Activity of Remdesivir for moderate COVID-19InterventionalGilead Sciences IncGilead Sciences IncOpen, With Recruitment25 March 2020
FLU-CATs : Evaluation and refinement of pandemic influenza community assessment toolsObservationalNIHRUniversity of LiverpoolOpen to Recruitment20 March 2020
The PRIEST StudyObservationalNIHRSHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUSTOpen to Recruitment20 March 2020
UKOSS: Pandemic Influenza in PregnancyObservationalNIHRUniversity of OxfordOpen to Recruitment20 March 2020
A phase I/II trial of a candidate COVID-19 vaccine (COV001)InterventionalMedical Research CouncilUniversity of OxfordOpen to Recruitment11 March 2020
PRINCIPLEInterventionalNIHR/UKRIUniversity of OxfordOpen, With Recruitment11 March 2020
RECOVERY trialInterventionalNIHR/UKRIUniversity of OxfordOpen, With Recruitment11 March 2020
nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2Pre-clinicalNIHR/UKRInot availablenot available11 March 2020
Rapid development of manufacturing processes for future production of adenovirus-vectored COVID19 vaccine at million-dose scalePre-clinicalNIHR/UKRIUniversity of Oxfordnot available11 March 2020
Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced DiseasePre-clinicalNIHR/UKRIQueens University Belfastnot available11 March 2020
Clinical Characterisation Protocol for Severe Emerging InfectionObservationalWellcome TrustUniversity of OxfordOpen, With Recruitment24 January 2020

Datasource:- NIHR

Research

Contact Us